In a ZCC arbitration, CRA was retained to provide expert reports and testimony regarding the damages suffered by claimant due to the termination of a co-promotion agreement for the commercialization of a pharmaceutical in Germany. As part of the damages assessment, CRA analyzed the German market for the product and the relative contribution to sales performance by each co-promotion partner.
Investment treaty disputes in the life sciences industry
In its global scale and economic impact, the life sciences industry presents unique considerations for investment treaty arbitrations. Recently, the COVID-19...